Richard Motruk has over 15 years of combined experience in the biopharmaceutical and medical device industries. He earned a Bachelor of Science in Biochemistry and Molecular Biology from Penn State University.
“Kymanox is highly regarded for its expertise in many facets of CGMP manufacturing, chemistry and related controls,” he said. “The idea of joining an industry leader and being able to parlay my operational leadership experience gained at bioMérieux, Teva, and OraSure, is very exciting.”
CEO and Founder, Stephen M. Perry remarked: “With Richard now directing our established Process Operations and Validation groups, this new leadership position lays a solid foundation for future, sustainable growth.”